Statera Biopharma Pink Sheet Forecast - Price Action Indicator
| STAB Stock | USD 0.0002 0.0001 100.00% |
Statera Pink Sheet outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Statera Biopharma stock prices and determine the direction of Statera Biopharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Statera Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The relative strength index (RSI) of Statera Biopharma's share price is at 52. This usually implies that the pink sheet is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Statera Biopharma, making its price go up or down. Momentum 52
Impartial
Oversold | Overbought |
Using Statera Biopharma hype-based prediction, you can estimate the value of Statera Biopharma from the perspective of Statera Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
Statera Biopharma after-hype prediction price | USD 1.83E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Statera |
Statera Biopharma Additional Predictive Modules
Most predictive techniques to examine Statera price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Statera using various technical indicators. When you analyze Statera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Statera Biopharma Volatility | Backtest Statera Biopharma | Information Ratio |
Statera Biopharma Trading Date Momentum
| On January 27 2026 Statera Biopharma was traded for 0.0002 at the closing time. The top price for the day was 0.0002 and the lowest listed price was 0.0002 . There was no trading activity during the period 1.0. Lack of trading volume on January 27, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 0.00% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Statera Biopharma to competition |
Other Forecasting Options for Statera Biopharma
For every potential investor in Statera, whether a beginner or expert, Statera Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Statera Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Statera. Basic forecasting techniques help filter out the noise by identifying Statera Biopharma's price trends.Statera Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Statera Biopharma pink sheet to make a market-neutral strategy. Peer analysis of Statera Biopharma could also be used in its relative valuation, which is a method of valuing Statera Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Statera Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Statera Biopharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Statera Biopharma shares will generate the highest return on investment. By undertsting and applying Statera Biopharma pink sheet market strength indicators, traders can identify Statera Biopharma entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 2.0 | |||
| Day Median Price | 2.0E-4 | |||
| Day Typical Price | 2.0E-4 | |||
| Price Action Indicator | 1.0E-4 | |||
| Period Momentum Indicator | 1.0E-4 | |||
| Relative Strength Index | 52.6 |
Statera Biopharma Risk Indicators
The analysis of Statera Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Statera Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting statera pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 29.24 | |||
| Semi Deviation | 21.51 | |||
| Standard Deviation | 50.08 | |||
| Variance | 2508.3 | |||
| Downside Variance | 4409.72 | |||
| Semi Variance | 462.83 | |||
| Expected Short fall | (116.67) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Statera Biopharma
The number of cover stories for Statera Biopharma depends on current market conditions and Statera Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Statera Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Statera Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Statera Biopharma Short Properties
Statera Biopharma's future price predictability will typically decrease when Statera Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Statera Biopharma often depends not only on the future outlook of the potential Statera Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Statera Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 35.1 M | |
| Cash And Short Term Investments | 2 M |
Other Information on Investing in Statera Pink Sheet
Statera Biopharma financial ratios help investors to determine whether Statera Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Statera with respect to the benefits of owning Statera Biopharma security.